Loading data for ALLR — first visit, this takes a few seconds.

Preisalarm

Allarity Therapeutics Inc... (ALLR)

NasdaqCM: ALLR · Echtzeitkurs · USD

1.36

+0.01 (0.74%)

Zum Schluss: Aug 18, 2026, 3:55 PM

0.74% (1D)

Geld	0.99
Marktkapitalisierung	21.64 Mio
Umsatz (TTM)	345K
Nettogewinn (TTM)	-11.25 Mio
Beta	0.51
EPS (ttm)	-0.79
KGV (TTM)	n/a
Forward-KGV	-1.4
KBV (TTM)	2.64
KUV (TTM)	62.72
Earnings Date	n/a

Brief	1.76
Volumen	9,293
Ø Vol. (20D)	143,938
Eröffnung	1.35
Vortagesschluss	1.35
Tagesspanne	1.35 - 1.39
52-Wk Range	0.77 - 2.35
Analyst	n/a
Kursziel	n/a
Dividenden	n/a
Ex-Dividenden-Datum	n/a

Über ALLR

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of po...

[Mehr lesen]

Branche Biotechnology

Sektor Healthcare

IPO Datum Dec 21, 2021

Mitarbeiter 7

Börse NasdaqCM

Tickersymbol ALLR

Website https://www.allarity.com

Vollständiges Unternehmensprofil

Finanzielle Entwicklung

Im Jahr 2025 betrug der Umsatz von Allarity Therapeutics 320K, ein Anstieg von undefined% im Vergleich zum Vorjahr (0). Der Gewinn lag bei -11.23 Mio, ein Rückgang von -54.19 %.

Finanzberichte

Gewinnüberraschung

Allarity Therapeutics hat die Quartalszahlen am Aug 14, 2026 veröffentlicht:

Umsatz von $25K verfehlt die Erwartungen um $0, mit Infinity% Wachstum im Jahresvergleich.

EPS von -0.21 übertrifft die Erwartungen um 0.04, mit -40.00% Rückgang im Jahresvergleich.

Nachrichten

vor 3 Wochen · Zacks

Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and ANIXA BIOSCIENCES INC (ANIX) have performed compared to their sector so far this year.

vor 1 Monat · Zacks

Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Amgen (AMGN) have performed compared to their sector so far this year.

vor 2 Monaten · Zacks

Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?

Here is how Allarity Therapeutics, Inc. (ALLR) and Alterity Therapeutics Limited - Sponsored ADR (ATHE) have performed compared to their sector so far this year.

vor 3 Monaten · Zacks

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Here is how Bioventus (BVS) and Allarity Therapeutics, Inc. (ALLR) have performed compared to their sector so far this year.

vor 5 Monaten · TipRanks

Allarity closes $20M financing for stenoparib advancement

Allarity (ALLR) Therapeutics closed a $20 million non-convertible debt financing with Streeterville Capital. The transaction is structured as a note purchase agreement pursuant to which the Company is...

Seite 1 von 2

Allarity Therapeutics Inc... (ALLR)